| Patents for C12N 5 - Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor (182,629) |
|---|
| 06/10/2004 | WO2004048595A2 Vascular-preferred promoters |
| 06/10/2004 | WO2004048574A1 Immunoreceptor proteins |
| 06/10/2004 | WO2004048568A1 UTILIZATION OF mKank GENE IN CANTER THERAPY, CANER DETECTION AND DRUG DISCOVERY |
| 06/10/2004 | WO2004048557A1 Treatment of tissue with undifferentiated mesenchymal cells |
| 06/10/2004 | WO2004048556A1 Method for culturing cells in order to produce substances |
| 06/10/2004 | WO2004048555A1 Restoration of methylation states in cells |
| 06/10/2004 | WO2004048543A2 Methods and compositions for controlling valency of phage display |
| 06/10/2004 | WO2004048531A2 Modulation of death-associated protein kinase 1 expression |
| 06/10/2004 | WO2004048527A2 Cells resistant to chemotherapeutic compounds and uses thereof |
| 06/10/2004 | WO2004048524A2 Modulation of stat2 expression |
| 06/10/2004 | WO2004048523A2 Modulation of ku86 expression |
| 06/10/2004 | WO2004048512A2 Novel proteins and nucleic acids encoding same |
| 06/10/2004 | WO2004048408A2 Asb-a transcription repressor proteins and nucleic acids and their application in expansion of stem cells |
| 06/10/2004 | WO2004048406A1 Nucleic acid comprising a sequence encoding a modified glutenin polypeptide |
| 06/10/2004 | WO2004048402A2 A hepatitis c virus codon optimized non-structural ns3/4a fusion gene |
| 06/10/2004 | WO2004048325A2 Modulation of jagged 1 expression |
| 06/10/2004 | WO2004047860A2 Cells not presenting antigen for suppressing pathological immune reactions |
| 06/10/2004 | WO2004047770A2 Cytotherapeutics, cytotherapeutic units and methods for treatments using them |
| 06/10/2004 | WO2004047747A2 Compositions and methods for cell dedifferentiation and tissue regeneration |
| 06/10/2004 | WO2004047731A2 Modulation of notch3 expression |
| 06/10/2004 | WO2004047622A2 Substantially non-immunogenic injectable collagen |
| 06/10/2004 | WO2004047620A2 Fixation method for bioprostheses |
| 06/10/2004 | WO2004047612A2 Methods of therapy and diagnosis |
| 06/10/2004 | WO2004033672A3 Stem cell expansion factor blocking a gene limiting hox-induced expansion and method using such factor |
| 06/10/2004 | WO2004029576A3 Cell-based fluorescence resonance energy transfer (fret) assays for clostridial toxins |
| 06/10/2004 | WO2004029278A3 Aav itr-mediated modulation |
| 06/10/2004 | WO2004024746A9 Therapeutic anti-bgp(c-cam1) antibodies and uses thereof |
| 06/10/2004 | WO2004013285A3 Human g protein-coupled receptor and modulators thereof for the treatment of ischemic heart disease and congestive heart failure |
| 06/10/2004 | WO2004011647A8 Modified small interfering rna molecules and methods of use |
| 06/10/2004 | WO2004011484A9 Parathyroid hormone receptor activation and hematopoietic progenitor cell expansion |
| 06/10/2004 | WO2004005488A3 Replacing liver cells with bone marrow-derived cells for treating disease and expressing therapeutic genes |
| 06/10/2004 | WO2003104470A3 Retrons for gene targeting |
| 06/10/2004 | WO2003099230A3 Electroprocessed collagen and tissue engineering |
| 06/10/2004 | WO2003083039A8 Therapeutic polypeptides, nucleic acids encoding same, and methods of use |
| 06/10/2004 | WO2003078567A3 Methods of inducing differentiation in ex vivo expanded stem cells |
| 06/10/2004 | WO2003068917A3 Functionalization of carotenoid compounds |
| 06/10/2004 | WO2003065986A3 FcϵRI-BEARING HUMAN MAST CELL LINES |
| 06/10/2004 | WO2003054188A3 Seminal vesicle tissue-specific promoters and uses thereof |
| 06/10/2004 | WO2003054142A3 Novel sulfurylase-luciferase fusion proteins and thermostable sulfurylase |
| 06/10/2004 | WO2003044057A3 Use of obg3 for promoting central nervous system remyelination |
| 06/10/2004 | WO2003040170A9 Antibodies to cd40 |
| 06/10/2004 | WO2003026689A8 Autologous growth factor cocktail composition, method of production and use |
| 06/10/2004 | WO2003015711A3 Combination motif immune stimulatory oligonucleotides with improved activity |
| 06/10/2004 | WO2003012082A3 Method for modulating stem cell differentiation using stem loop rna |
| 06/10/2004 | WO2003007800A9 Methods for diagnosing and treating diseases and conditions of the digestive system and cancer |
| 06/10/2004 | WO2002083845A3 Modulation of primary stem cell differentiation |
| 06/10/2004 | WO2002040629A3 Promoters exhibiting endothelial cell specificity and methods of using same |
| 06/10/2004 | US20040111769 Sugar beet genes involved in stress tolerance |
| 06/10/2004 | US20040111768 Transcription factor stress-related proteins and methods of use in plants |
| 06/10/2004 | US20040111758 Mammalian cancer cell and transgenic mammal carrying human protooncogene and kit for diagnosing cancer using said protooncogene |
| 06/10/2004 | US20040110934 Human mitochondrial proteins and polynucleotides encoding the proteins |
| 06/10/2004 | US20040110919 Comprises toxic jellyfish protein for use as pesticide |
| 06/10/2004 | US20040110715 Differs from nucleotide sequence of wild-type IFN alpha -17 gene, in that it comprises one or several SNPs (Single Nucleotide Polymorphism[s]); anticarcinogenic and antiproliferative agents; side effect reduction |
| 06/10/2004 | US20040110706 Nucleic acid with point mutations, deletions, insertions and/or rearrangements ; hyperthermia, myasthenia, ataxia, neuropathic and inflammatory pain; Alzheimer*s, Parkinson's disease; schizophrenia, hyperekplexia, myotonias and arrhythmia |
| 06/10/2004 | US20040110703 Gene expression inhibition; molecular hybridization; drug screening, medical diagnosis |
| 06/10/2004 | US20040110695 Phospholipid vesicle having exogenous antigen orpolynucleic acid coding for antigen; adapted to be phagocytosed by antigen presenting cells |
| 06/10/2004 | US20040110682 Nucleic acid construct for expressing active substances which can be activated by proteases, and preparation and use |
| 06/10/2004 | US20040110680 Beta-alethine use in cell culture and therapy |
| 06/10/2004 | US20040110677 Stimulating differentiation in growth of osteoblasts and osteoclasts; wound healing of bone fractures and de novo bone formation; osteoporosis; bone cancer treatment; polynucleotide encoding polypeptide; genetic engineering |
| 06/10/2004 | US20040110674 Nucleic acid and corresponding protein entitled 205p1b5 useful in treatment and detection of cancer |
| 06/10/2004 | US20040110668 Nucleic acid sequences differentially expressed in cancer tissue |
| 06/10/2004 | US20040110290 Cell matrix comprising immobilized transgenic cells for diagnosis and treatment breast cancer |
| 06/10/2004 | US20040110289 Obtaining liver cells suspension via proteolytic digestion followed by density gradient centrifugation; liver regeneration and transplantation therapy |
| 06/10/2004 | US20040110288 Neuronal multipotent cell culture for use in the treatment of nervous system disorders and spinal cord injury; drug screening; tissue engineering; cell transplantation therapy |
| 06/10/2004 | US20040110287 Culturing pancreatic tissue for use in replenishment of functional glucose-sensing, insulin-secreting pancreatic beta cells; pancreatic injury and diabetes treatments |
| 06/10/2004 | US20040110286 Method for making hematopoietic cells |
| 06/10/2004 | US20040110285 Biological scaffolds seeded with cells and comprised of biocompatible and biodegradable shape memory ("SM") polymers for use in culture manipulation and propagation |
| 06/10/2004 | US20040110283 Induction of tumor and viral immunity using antigen presenting cell co-culture products and fusion products |
| 06/10/2004 | US20040110273 Culture chamber for biologicals |
| 06/10/2004 | US20040110268 Attenuated Pasteurellaceae virulence genes are identified and used to screen bactericides and produce vaccines which prevent infection |
| 06/10/2004 | US20040110260 Recombinant minimal catalytic vanadium haloperoxidases and their uses |
| 06/10/2004 | US20040110257 Production of farnesol and geranylgeraniol |
| 06/10/2004 | US20040110254 Method for producing alpha-1, 6-branched alph-1, 4-glucans from sucrose |
| 06/10/2004 | US20040110253 used in studying T cells and their antigenic targets in autoimmunity, hypersensitivity, and cancer; for drug screening; genetic engineering |
| 06/10/2004 | US20040110250 Materials and methods relating to protein aggregation in neurodegenerative disease |
| 06/10/2004 | US20040110236 comprises administering the hepatocytes or plasma cells or T cells to an animal after stimulation in vitro |
| 06/10/2004 | US20040110218 BMOG, a novel protein member of the myelin-oligodendrocyte glycoprotein family and its use for immunomodulatory purposes |
| 06/10/2004 | US20040110202 Isolated nucleic acid comprising a polynucleotide of given sequence encoding a polypeptide; culturing cell line which alters a beta processing; use in treatment of Alzheimer's disease. |
| 06/10/2004 | US20040110190 Isolated nucleic acid comprising a polynucleotide encoding a polypeptide which has expansin activity; altering properties which may effect growth, flexibility, and mechanical strength in tissues in which they are expressed; use in paper industry |
| 06/10/2004 | US20040110184 Identifying insecticidal protein specific to lepidopteran pests; cry proteins as biological pest control agents |
| 06/10/2004 | US20040110181 Novel streptococcus pneumoniae open reading frames encoding polypeptide antigens and uses thereof |
| 06/10/2004 | US20040110180 Comprises enzymatic polypeptide for diagnosis, treatment and prevention of cardiovascular, immune system, nervous system, lipid and cell proliferative disorders; drug screening |
| 06/10/2004 | US20040110173 Haplotype partitioning in the proximal promoter of the human growth hormone (GH1) gene |
| 06/10/2004 | US20040110127 Screening methods for identifying compounds which decrease HIV entry into a cell |
| 06/10/2004 | US20040109878 Removal cancer, organ transplant and autoimmune cells from bone marrow, blood |
| 06/10/2004 | US20040109873 Genetic engineering equine herpes virus; genes coding protein |
| 06/10/2004 | US20040109851 Use of immature dendritic cells to silence antigen specific cd8cell function |
| 06/10/2004 | CA2507460A1 Nucleic acid comprising a sequence encoding a modified glutenin polypeptide |
| 06/10/2004 | CA2506820A1 A hepatitis c virus codon optimized non-structural ns3/4a fusion gene |
| 06/10/2004 | CA2506683A1 Compositions and methods for cell dedifferentiation and tissue regeneration |
| 06/10/2004 | CA2506569A1 Treatment of tissue with undifferentiated mesenchymal cells |
| 06/10/2004 | CA2506356A1 Methods of therapy and diagnosis |
| 06/10/2004 | CA2505534A1 Cytotherapeutics, cytotherapeutic units and methods for treatments using them |
| 06/09/2004 | EP1426066A1 Scaffold product for human bone tissue engineering, methods for its preparation and uses thereof |
| 06/09/2004 | EP1426021A1 Implantable system with drug eluting cells for on-demand local drug delivery |
| 06/09/2004 | EP1425679A2 Arrangement with artificial neurons for describing the transmission behavior of a nerve cell to be excited and method for determining the transmission behavior of a nerve cell to be excited using artificial neurons |
| 06/09/2004 | EP1425580A2 Lymphatic endothelial cells materials and methods |
| 06/09/2004 | EP1425404A2 Vaccinia virus mva-e3l-knockout-mutants and use thereof |
| 06/09/2004 | EP1425397A2 Modified cry3a toxins and nucleic acid sequences coding therefor |
| 06/09/2004 | EP1425396A2 Dna encoding the major allergen of plantago lanceolata pollen, pla 11 |